Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Prasanna Jagannathan, Jason R. Andrews, Hector Bonilla, Haley Hedlin, Karen B. Jacobson, Vidhya Balasubramanian, Natasha Purington, Savita Kamble, Christiaan R. de Vries, Orlando Quintero, Kent Feng, Catherine Ley, Dean Winslow, Jennifer Newberry, Karlie Edwards, Colin Hislop, Ingrid Choong, Yvonne Maldonado, Jeffrey Glenn, Ami Bhatt, Catherine Blish, Taia Wang, Chaitan Khosla, Benjamin A. Pinsky, Manisha Desai, Julie Parsonnet, Upinder Singh
doi: https://doi.org/10.1101/2020.11.18.20234161
Prasanna Jagannathan
1Department of Medicine, Stanford University, Stanford, CA, USA
2Department of Microbiology and Immunology, Stanford University, Stanford, CA USA
Jason R. Andrews
1Department of Medicine, Stanford University, Stanford, CA, USA
Hector Bonilla
1Department of Medicine, Stanford University, Stanford, CA, USA
Haley Hedlin
3Quantitative Sciences Unit, Stanford University, Stanford, CA, USA
Karen B. Jacobson
1Department of Medicine, Stanford University, Stanford, CA, USA
Vidhya Balasubramanian
3Quantitative Sciences Unit, Stanford University, Stanford, CA, USA
Natasha Purington
3Quantitative Sciences Unit, Stanford University, Stanford, CA, USA
Savita Kamble
4Stanford Center for Clinical Research, Stanford University, Stanford, CA USA
Christiaan R. de Vries
1Department of Medicine, Stanford University, Stanford, CA, USA
Orlando Quintero
1Department of Medicine, Stanford University, Stanford, CA, USA
Kent Feng
4Stanford Center for Clinical Research, Stanford University, Stanford, CA USA
Catherine Ley
1Department of Medicine, Stanford University, Stanford, CA, USA
Dean Winslow
1Department of Medicine, Stanford University, Stanford, CA, USA
Jennifer Newberry
5Department of Emergency Medicine, Stanford University, Stanford, CA, USA
Karlie Edwards
1Department of Medicine, Stanford University, Stanford, CA, USA
Colin Hislop
6Department of Pediatrics, Stanford University, Stanford, CA, USA
Ingrid Choong
6Department of Pediatrics, Stanford University, Stanford, CA, USA
Yvonne Maldonado
7Eiger BioPharmaceuticals, Palo Alto, CA, USA
Jeffrey Glenn
1Department of Medicine, Stanford University, Stanford, CA, USA
2Department of Microbiology and Immunology, Stanford University, Stanford, CA USA
Ami Bhatt
1Department of Medicine, Stanford University, Stanford, CA, USA
8Department of Genetics, Stanford University, Stanford, CA USA
Catherine Blish
1Department of Medicine, Stanford University, Stanford, CA, USA
Taia Wang
1Department of Medicine, Stanford University, Stanford, CA, USA
2Department of Microbiology and Immunology, Stanford University, Stanford, CA USA
Chaitan Khosla
9ChEM-H, Stanford University, Stanford, CA USA
Benjamin A. Pinsky
1Department of Medicine, Stanford University, Stanford, CA, USA
10Department of Pathology, Stanford University, Stanford, CA USA
Manisha Desai
3Quantitative Sciences Unit, Stanford University, Stanford, CA, USA
Julie Parsonnet
1Department of Medicine, Stanford University, Stanford, CA, USA
Upinder Singh
1Department of Medicine, Stanford University, Stanford, CA, USA
2Department of Microbiology and Immunology, Stanford University, Stanford, CA USA
Data Availability
Data will be made available at Stanford Digital Repository, lane.stanford.edu, at time of final publication.
Posted November 23, 2020.
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Prasanna Jagannathan, Jason R. Andrews, Hector Bonilla, Haley Hedlin, Karen B. Jacobson, Vidhya Balasubramanian, Natasha Purington, Savita Kamble, Christiaan R. de Vries, Orlando Quintero, Kent Feng, Catherine Ley, Dean Winslow, Jennifer Newberry, Karlie Edwards, Colin Hislop, Ingrid Choong, Yvonne Maldonado, Jeffrey Glenn, Ami Bhatt, Catherine Blish, Taia Wang, Chaitan Khosla, Benjamin A. Pinsky, Manisha Desai, Julie Parsonnet, Upinder Singh
medRxiv 2020.11.18.20234161; doi: https://doi.org/10.1101/2020.11.18.20234161
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Prasanna Jagannathan, Jason R. Andrews, Hector Bonilla, Haley Hedlin, Karen B. Jacobson, Vidhya Balasubramanian, Natasha Purington, Savita Kamble, Christiaan R. de Vries, Orlando Quintero, Kent Feng, Catherine Ley, Dean Winslow, Jennifer Newberry, Karlie Edwards, Colin Hislop, Ingrid Choong, Yvonne Maldonado, Jeffrey Glenn, Ami Bhatt, Catherine Blish, Taia Wang, Chaitan Khosla, Benjamin A. Pinsky, Manisha Desai, Julie Parsonnet, Upinder Singh
medRxiv 2020.11.18.20234161; doi: https://doi.org/10.1101/2020.11.18.20234161
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12560)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (401)
- Health Economics (716)
- Health Informatics (2850)
- Health Policy (1048)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4194)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6782)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (201)
- Urology (174)